JUL 15, 2020 8:00 AM PDT

Adapting to succeed - perspectives from leaders in industry and academia using flow cytometry for COVID-19 research

Sponsored by: Sony Biotechnology
C.E. Credits: P.A.C.E. CE Florida CE
  • CEO - Immune BioSolutions
      CEO and co-founder of Immune Biosolutions, a biotech company focusing on the fast discovery and engineering of next-generation biologics through its proprietary chicken antibody discovery platform. Dr Leduc holds a PhD from the University of Sherebrook and has a background in Biochemistry, Biotechnology and Ecotoxicology.
    • Associate Professor, Medicine - University of California San Francisco
        Associate Professor of Medicine at University of California San Francisco and the Director of the UCSF Core Immunology Laboratory. Dr Milush holds a PhD from the University of Texas and has a background in molecular microbiology.
      • Associate Director - Flow Cytometry Facility (Broad Institute of MIT and Harvard)
          Associate Director of the Flow Cytometry Core Facility at Broad Institute of Harvard and MIT. Patricia has been leading the flow core for the past 5 years and has a background in General Biology and Microbiology.


        DATE:  July 15, 2020

        TIME:   8:00am PDT, 11:00am EDT


        Self-isolation and quarantine measures taken by many nations during the SARS-CoV-2 (COVID-19) pandemic have had a considerable impact on research laboratories, but scientists have adapted quickly and continue to support the many studies on the virus that are underway. These investigations range from research on immunopathology, diagnostics and therapeutics to understanding the biomarkers and epigenetics underlying the susceptibility of different individuals. Academic core facilities such as flow cytometry labs are essential support services that researchers rely on daily for these studies, and they have been working diligently to adjust to the changing times.


        We have invited leaders from academic core labs and the life science industry who support the discovery and therapeutics efforts against COVID-19.  They will discuss the best practices that are being adopted to minimize individual risk while handling COVID-19 infected specimens, as well as emerging research areas that focus on the use of cell sorting in a workflow for therapeutic antibody screening and identification.


        Sony Biotechnology is proud to support and work with teams like these across the globe.


        Join us for what promises to be a very informative discussion.


        Learning Objectives:

        • Understand how research labs are adapting to support COVID-19 research
        • Learn about flow cytometry approaches used for studying COVID-19 immunopathology
        • Hear about the use of flow cytometry in the discovery of COVID-19 neutralizing antibodies



        Webinars will be available for unlimited on-demand viewing after live event.
        LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

        Show Resources
        Show Resources
        • See more